Genting Malaysia Berhad Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
Genting Malaysia Berhad wird ein jährliches Gewinn- und Umsatzwachstum von 29.2% bzw. 5.3% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 28.9% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 9% betragen.
Wichtige Informationen
29.0%
Wachstumsrate der Gewinne
28.2%
EPS-Wachstumsrate
| Hospitality Gewinnwachstum | 21.6% |
| Wachstumsrate der Einnahmen | 4.4% |
| Zukünftige Eigenkapitalrendite | 8.9% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 05 Sep 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Analysts Have Made A Financial Statement On Genting Malaysia Berhad's (KLSE:GENM) Second-Quarter Report
Sep 01
Returns On Capital At Genting Malaysia Berhad (KLSE:GENM) Have Stalled
Jun 28Is There An Opportunity With Genting Malaysia Berhad's (KLSE:GENM) 25% Undervaluation?
May 28There May Be Underlying Issues With The Quality Of Genting Malaysia Berhad's (KLSE:GENM) Earnings
Apr 30Genting Malaysia Berhad (KLSE:GENM) Seems To Use Debt Quite Sensibly
Mar 28Genting Malaysia Berhad (KLSE:GENM) Has Some Way To Go To Become A Multi-Bagger
Mar 15Genting Malaysia Berhad's (KLSE:GENM) Share Price Could Signal Some Risk
Mar 02An Intrinsic Calculation For Genting Malaysia Berhad (KLSE:GENM) Suggests It's 23% Undervalued
Feb 04Is Genting Malaysia Berhad (KLSE:GENM) Potentially Undervalued?
Jan 20These 4 Measures Indicate That Genting Malaysia Berhad (KLSE:GENM) Is Using Debt Reasonably Well
Nov 06Genting Malaysia Berhad's (KLSE:GENM) Intrinsic Value Is Potentially 56% Above Its Share Price
Oct 19Sentiment Still Eluding Genting Malaysia Berhad (KLSE:GENM)
Sep 28Genting Malaysia Berhad's (KLSE:GENM) Dividend Will Be MYR0.06
Aug 28Genting Malaysia Berhad (KLSE:GENM) Has A Somewhat Strained Balance Sheet
Aug 03Genting Malaysia Berhad (KLSE:GENM) Has More To Do To Multiply In Value Going Forward
Jul 14A Look At The Intrinsic Value Of Genting Malaysia Berhad (KLSE:GENM)
Jun 14We Think Genting Malaysia Berhad (KLSE:GENM) Is Taking Some Risk With Its Debt
Apr 11The Returns At Genting Malaysia Berhad (KLSE:GENM) Aren't Growing
Mar 20Genting Malaysia Berhad's (KLSE:GENM) Intrinsic Value Is Potentially 28% Above Its Share Price
Feb 17We Think Genting Malaysia Berhad's (KLSE:GENM) Robust Earnings Are Conservative
Dec 01Here's Why Genting Malaysia Berhad (KLSE:GENM) Has A Meaningful Debt Burden
Nov 22Is Genting Malaysia Berhad (KLSE:GENM) Trading At A 42% Discount?
Oct 26Genting Malaysia Berhad (KLSE:GENM) Could Be Struggling To Allocate Capital
Sep 29Genting Malaysia Berhad (KLSE:GENM) Is Carrying A Fair Bit Of Debt
Aug 18Are Investors Undervaluing Genting Malaysia Berhad (KLSE:GENM) By 40%?
May 22Here's Why Genting Malaysia Berhad (KLSE:GENM) Can Afford Some Debt
Apr 29Genting Malaysia Berhad (KLSE:GENM) Is Paying Out A Larger Dividend Than Last Year
Feb 27Is There Now An Opportunity In Genting Malaysia Berhad (KLSE:GENM)?
Feb 09Genting Malaysia Berhad's (KLSE:GENM) Intrinsic Value Is Potentially 71% Above Its Share Price
Jan 19Is Genting Malaysia Berhad (KLSE:GENM) Potentially Undervalued?
Nov 01Is There An Opportunity With Genting Malaysia Berhad's (KLSE:GENM) 22% Undervaluation?
Sep 18We Think Genting Malaysia Berhad (KLSE:GENM) Has A Fair Chunk Of Debt
Aug 24Is Now An Opportune Moment To Examine Genting Malaysia Berhad (KLSE:GENM)?
May 16Genting Malaysia Berhad (KLSE:GENM) Is Carrying A Fair Bit Of Debt
Jan 14
Are Dividend Investors Making A Mistake With Genting Malaysia Berhad (KLSE:GENM)?
Dec 19Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 12,050 | 1,227 | 2,247 | 2,663 | 13 |
| 12/31/2025 | 11,514 | 1,029 | 2,264 | 2,595 | 14 |
| 12/31/2024 | 10,893 | 780 | 2,367 | 2,525 | 14 |
| 6/30/2024 | 10,866 | 557 | 2,018 | 2,649 | N/A |
| 3/31/2024 | 10,671 | 522 | 1,827 | 2,504 | N/A |
| 12/31/2023 | 10,189 | 437 | 1,626 | 2,322 | N/A |
| 9/30/2023 | 9,903 | -197 | 1,292 | 2,043 | N/A |
| 6/30/2023 | 9,464 | -363 | 1,604 | 2,376 | N/A |
| 3/31/2023 | 9,165 | -421 | 1,686 | 2,427 | N/A |
| 12/31/2022 | 8,603 | -520 | 1,679 | 2,363 | N/A |
| 9/30/2022 | 8,058 | 48 | 1,915 | 2,560 | N/A |
| 6/30/2022 | 6,612 | -252 | 1,155 | 1,864 | N/A |
| 3/31/2022 | 5,255 | -590 | 321 | 1,104 | N/A |
| 12/31/2021 | 4,157 | -947 | -405 | 471 | N/A |
| 9/30/2021 | 3,309 | -1,362 | -1,449 | -503 | N/A |
| 6/30/2021 | 3,899 | -1,777 | -1,252 | -299 | N/A |
| 3/31/2021 | 3,196 | -2,329 | -1,550 | -567 | N/A |
| 12/31/2020 | 4,529 | -2,264 | -1,561 | -481 | N/A |
| 9/30/2020 | 5,930 | -1,723 | -1,084 | 211 | N/A |
| 6/30/2020 | 7,141 | -608 | -818 | 672 | N/A |
| 3/31/2020 | 9,627 | 709 | -466 | 1,883 | N/A |
| 12/31/2019 | 10,407 | 1,395 | 56 | 2,577 | N/A |
| 9/30/2019 | 10,472 | 1,816 | -32 | 2,604 | N/A |
| 6/30/2019 | 10,443 | -89 | 147 | 2,783 | N/A |
| 3/31/2019 | 10,264 | -109 | 708 | 2,644 | N/A |
| 12/31/2018 | 9,928 | -19 | 757 | 2,611 | N/A |
| 9/30/2018 | 9,965 | -290 | 913 | 2,649 | N/A |
| 6/30/2018 | 9,636 | 1,398 | 327 | 2,325 | N/A |
| 3/31/2018 | 9,506 | 1,196 | N/A | 2,197 | N/A |
| 12/31/2017 | 9,330 | 1,161 | N/A | 2,155 | N/A |
| 9/30/2017 | 9,069 | 2,398 | N/A | 2,372 | N/A |
| 6/30/2017 | 8,999 | 2,760 | N/A | 2,240 | N/A |
| 3/31/2017 | 8,941 | 3,042 | N/A | 2,424 | N/A |
| 12/31/2016 | 8,932 | 2,880 | N/A | 2,409 | N/A |
| 9/30/2016 | 8,941 | 1,532 | N/A | 1,906 | N/A |
| 6/30/2016 | 8,769 | 1,303 | N/A | 1,905 | N/A |
| 3/31/2016 | 8,517 | 1,057 | N/A | 1,748 | N/A |
| 12/31/2015 | 8,396 | 1,258 | N/A | 1,857 | N/A |
| 9/30/2015 | 8,162 | 1,229 | N/A | 2,058 | N/A |
| 6/30/2015 | 8,369 | 1,169 | N/A | 1,958 | N/A |
| 3/31/2015 | 8,296 | 1,193 | N/A | 1,604 | N/A |
| 12/31/2014 | 8,229 | 1,189 | N/A | 1,541 | N/A |
| 9/30/2014 | 8,292 | 1,279 | N/A | 1,602 | N/A |
| 6/30/2014 | 8,178 | 1,336 | N/A | 1,629 | N/A |
| 3/31/2014 | 8,492 | 1,542 | N/A | 2,169 | N/A |
| 12/31/2013 | 8,328 | 1,603 | N/A | 2,102 | N/A |
| 9/30/2013 | 8,134 | 1,648 | N/A | 2,152 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: GENMDas prognostizierte Gewinnwachstum (29.2% pro Jahr) liegt über der Sparquote (3.6%).
Ertrag vs. Markt: GENMDie Erträge des Unternehmens (29.2% pro Jahr) werden voraussichtlich schneller wachsen als der Markt MY (12.4% pro Jahr).
Hohe Wachstumserträge: GENMEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: GENMDie Einnahmen des Unternehmens (5.3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt MY (6.1% pro Jahr).
Hohe Wachstumseinnahmen: GENMDie Einnahmen des Unternehmens (5.3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: GENMDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (9%).